Esco Aster partners with Shine-On Biomedical for HLA-G targeting exosome drug delivery platform

RedHill advances RHB-102 across GI indications

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic

ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA

Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe

Corcept announces receipt of FDA Complete Response letter for relacorilant in hypercortisolism

Axsome Therapeutics secures FDA priority review for AXS-05 in Alzheimer's disease agitation

Vanda's NEREUS approved by US FDA for prevention of motion sickness

Diamyd Medical agrees accelerated efficacy readout in ongoing Phase 3 type 1 diabetes trial

INOVIO's INO-3107 Biologics License Application accepted by US FDA

Citius Pharmaceuticals reports full-year financial results

Bioeq and Zydus partner for US commercialisation of Lucentis biosimilar NUFYMCO

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA